ROLE SUMMARY

Oncology is an exciting and dynamic area and a key priority for Pfizer.  This role has the potential to help set the future vision for Pfizer’s Oncology portfolio and to help make a significant difference in patient’s lives.
 

The Senior Director Franchise Lead, Oncology Commercial Development – Hematology Oncology is responsible for working with research, development, biopharma, BI partner functions and the cross functional team to drive decision-making for the early-stage, late-stage and business development opportunities in the Hematology Oncology Franchise. This role will be responsible for long term vision for the Hematology Oncology Franchise, commercial assessment, and investment case development for all early / late-stage assets, life cycle options and technology platforms.  In addition, the role will also be responsible for leading / supporting Hematology Oncology Franchise wide key strategic initiatives.

ROLE RESPONSIBILITIES

The candidate must be a self-starter who is able to multitask in a fast-paced and dynamic environment, lead cross functional teams, set vision, and support the team through key strategic decisions for Pfizer’s oncology portfolio.
 

Key responsibilities include:

This position will be a key interface to Oncology Research, Development and Biopharma; Medical, PDA, GAV, BD, Regulatory and all partner functions on new asset ideas, holistic early asset strategy, facilitate execution of asset plans and support asset progression through governance stage-gates and endorsements by TRIAD and enterprise governance bodies. You will play an important influential leadership role to foster a strong, collaborative partnership culture.

Lead commercial / strategic assessments and drive commercial planning to support development of asset / technology platform business cases including:

Lead and coordinate matrix team of Commercial Development Directors supporting specific assets in the franchise

Lead the commercial sub team (EPIC Team) for the franchise with colleagues from partner functions supporting commercial assessment and strategy development

Evaluating and maintaining a comprehensive view of the dynamic competitive landscape at the asset / MOA / Tumor level

Leading comprehensive analysis of the market trends, pricing/access landscape; treatment trends across regions; evolving standard of care and competitive developments

Providing commercial input to the development strategies to optimally develop oncology assets
 

In close partnership with key stakeholders, you will drive pipeline asset and disease area strategies, commercial assessments, develop product concepts, target product profiles, assess and recommend asset investment decisions incorporating competitive intelligence

Address strategic development questions and issues that directly impact early asset teams

Gather insights and advice that will directly impact early clinical strategies (such as clinical trial design, target indications and patient segments, endpoints, recruitment etc.)

Provide an early read and insights on external and competitive activities with the ability to impact team strategies and decisions rapidly
 

Lead the DP3 commercial assessment (for Phase 3 investments) for all assets in the franchise and make appropriate strategic and investment recommendations to TRIAD, and Pfizer governance bodies, incorporating franchise-wide strategic implications

Creating and updating portfolio decision making tools and systems to provide state of the art tools that are aligned and applied consistently across the portfolio

BASIC QUALIFICATIONS

BA/BS with 15+ years of experience in commercial development, marketing, new product launch or strategy in pharmaceutical, medical device or biotechnology companies.

Experience in leading Marketing and/or Commercial organizations is preferred.

PREFERRED QUALIFICATIONS

MS/MBA with 13 years of relevant experience.

Strong understanding of Oncology landscape and emerging trends highly preferred.

Prior Commercial Development experience with commercial planning, decision-making and driving value of early-stage pipeline assets highly preferred.

Experience progressing assets through stage-gates (POC, DP3 etc) and presenting asset business cases to senior management.

Hands-on experience leading financial valuation, forecasting, business proposal and/or other related projects required.

Experience interfacing/collaborating with Research, Development, Regulatory, PHI and other functions required.

Ability to influence without direct authority.

Demonstrated leadership of cross functional matrix teams and developing a collaborative culture highly preferred.

A high sense of urgency with a focus on driving decisions in the face of incomplete and imperfect information.

Experience in long term strategic plan development and execution.

Experience with Global product launches and developing pre-launch positioning and strategies.

ADDITIONAL INFORMATION

Location: On premise

The annual base salary for this position ranges from $205,400.00 to $342,400.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 25.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States.

Relocation assistance may be available based on business needs and/or eligibility.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations.  These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure.  Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act.  Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government.  If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status.  Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA.  Pfizer is an E-Verify employer.  This position requires permanent work authorization in the United States.

Marketing and Market Research

#LI-PFE